Press Releases

bioMérieux – First-Quarter 2019 Business Review

Organic growth of 3.8% (at constant exchange rates and scope of consolidation) €632 million in sales Up 7.7% as reported Growth led by the performance in molecular biology, during a first quarter shap...

“Global-PPS”, a survey of antibiotic use and bacterial resistance in hospitals worldwide, tops the 200,000 patients

bioMérieux, a world leader in the field of in vitro diagnostics, and the Laboratory of Medical Microbiology at the University of Antwerp announced at ECCMID (European Congress of Clinical Microbiology...

University of Antwerp, bioMérieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics

Antwerp (Belgium), London (UK), Marcy l’Etoile (France) – April 1, 2019 - The University of Antwerp, bioMérieux and Wellcome Trust today announced the launch of VALUE-Dx, the first Innovative Medicine...

Partnerships

Baxter et bioMérieux annoncent leur collaboration pour améliorer l'identification et le traitement de l’insuffisance rénale aiguë

Baxter International Inc. (NYSE:BAX), a global leader in acute care, and bioMérieux, a world leader in the field of in vitro diagnostics, announced an agreement to develop future biomarkers with the g...

bioMérieux – 2018 Financial Results

Organic sales growth of 9.9% for full-year 2018: €2,421 million in sales Up 5.8% as reported Solid fourth-quarter performance, with organic growth of more than 10% Improvement in contributive operatin...

bioMérieux acquires Invisible Sentinel, a US-based company specialized in food and beverage molecular testing

bioMérieux, a global player in in vitro diagnostics and world leader in food microbiology testing, today announced the acquisition of Invisible Sentinel Inc. This company, based in Philadelphia (PA) d...